Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions

NCT01723982 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
256
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals